E. Casado
About
In The Last Decade
E. Casado
104 papers receiving 3.9k citations
Hit Papers
Peers
Comparison fields: 5 of 139
- Molecular Biology 1.9k
- Oncology 1.2k
- Cancer Research 636
- Pathology and Forensic Medicine 589
- Pulmonary and Respiratory Medicine 502
Countries citing papers authored by E. Casado
This map shows the geographic impact of E. Casado's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Casado with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Casado more than expected).
Fields of papers citing papers by E. Casado
This network shows the impact of papers produced by E. Casado. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Casado. The network helps show where E. Casado may publish in the future.
Co-authorship network of co-authors of E. Casado
This figure shows the co-authorship network connecting the top 25 collaborators of E. Casado. A scholar is included among the top collaborators of E. Casado based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Casado. E. Casado is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 2 | |
| 3 | 3 | |
| 4 | 0 | |
| 5 | 1 | |
| 6 | 0 | |
| 7 | 9 | |
| 8 | 97 | |
| 9 | 7 | |
| 10 | 9 | |
| 11 | 0 | |
| 12 | 25 | |
| 13 | 39 | |
| 14 | Combined anti-EGFR blockade: A phase I pharmacokinetic and molecular pharmacodynamic study of Cetuximab (Erbitux (R)) and Gefitinib (Iressa (R)) in patients with advanced colorectal, head and neck and non-small cell lung cancer expressing the EGFR | 4 |
| 15 | 15 | |
| 16 | Administración de calcidiol y valores séricos de 25-OH-D3. ¿Qué pauta clínica utilizar? | 2 |
| 17 | Linfadenitis necrosante de Kikuchi-Fujimoto y su asociación con el lupus eritematoso sistémico: descripción de 4 nuevos casos | 2 |
| 18 | Un sistema de codificación en reumatología. Experiencia de 15 años | 1 |
| 19 | Pronóstico y tratamiento de la enfermedad de Still del adulto | 1 |
| 20 | Tratamiento con inmunoglobulina intravenosa en la aplasia pura de la serie roja en una paciente con lupus eritematoso sistémico | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.